Evaluation of ultraviolet irradiation efficacy in an automated system for the aseptic compounding using challenge test

International Journal for Quality in Health Care

Volumn 27, Issue 5, 2015, Pages 412-417

  Bruscolini, Francesca ^a   Paolucci, Demis ^b   Rosini, Valeria ^b   Sabatini, Luigia ^a   Andreozzi, Elisa ^a   Pianetti, Anna ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Loccioni Humancare   (Italy)

Author keywords

Aseptic drug compounding; Challenge test; UV efficiency

Indexed keywords

ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; ESCHERICHIA COLI; MICROBIAL AIR; MICROBIOLOGICAL PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PSEUDOMONAS AERUGINOSA; RADIATION STERILIZATION; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; ULTRAVIOLET RADIATION; BACTERIUM; DRUG FORMULATION; FUNGUS; HOSPITAL PHARMACY; HUMAN; INSTRUMENT STERILIZATION; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; PROCEDURES; ROBOTICS;

BACTERIA; DRUG COMPOUNDING; FUNGI; HUMANS; INJECTIONS, INTRAVENOUS; PHARMACY SERVICE, HOSPITAL; ROBOTICS; STERILIZATION; ULTRAVIOLET RAYS;

EID: 84943744448     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzv051     Document Type: Article

References (29)

1. Morimoto T, Gandhi TK, Seger AC et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004;13:306-14.
2. Al Ferayan A, Russell NA, AlWohaibi M et al. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection. Childs Nerv Syst 1999;15:87-9.
3. Klys M, Konopka T, Scislowski M et al. Fatality involving vinblastine overdose as a result of a complex medical error. Cancer Chemother Pharmacol 2007;59:89-95.
4. Ranchon F, Salles G, Späth H-M et al. Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer 2011;11:478-88.
5. Phillips J, Beam S, Brinker A et al. Retrospective analysis of mortalities associated with medication error. Am J Health Syst Pharm 2001;58:1835-41.
6. Sorsa M, Anderson D. Monitoring of occupational exposure to cytostatic anticancer agents. Mutat Res 1996;355:253-61.
7. ChaffeeBW, Armitstead JA, Benjamin BE et al. Guidelines for the safe handling of hazardous drugs: consensus recommendations. Am J Health Syst Pharm 2010;67:1545-6.
8. Connor TH, DeBord DG, Pretty JR et al. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med 2010;52:1019-27.
9. McDiarmid MA, Oliver MS, Roth TS et al. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med 2010;52:1028-34.
10. Seger AC, ChurchillWW, Keohane CA et al. Impact of robotic antineoplastic preparation on safety, workflow, and costs. J Oncol Pract 2012;8:344-9.
11. Yaniv AW, Knoer SJ. Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy. Am J Health Syst Pharm 2013;70:2030-7.
12. Masini C, Nanni O, Antarid S et al. Automation in the preparation of chemotherapy: quality improvement and economic sustainability. Am J Health Syst Pharm 2014;71:579-85.
13. Wolfe RL. Ultraviolet disinfection of potable water. Environ Sci Tech 1990;24:768-73.
14. Ansari IA, Datta AK. An overview of sterilization methods for packaging materials used in aseptic packaging system. Food Bioprod Process 2003;81:57-65.
15. United States Pharmacopeia. USP <51>. Antimicrobial effectiveness testing. Rockville, MD. http://www.pharmacopeia.cn/v29240/usp29nf24s0_c51.html (23 July 2015, date last accessed).
16. Anon EPA/OPP Microbiology Laboratory. Standard operating procedure for standard operating procedure for the AOAC sporicidal activity of disinfectants test (Bacillus × porcelain component only) SOP number: MB-15-01. U.S. Environmental Protection Agency 2006.
17. özçelik B. Fungi/bactericidal and static effects of ultraviolet light in 254 and 354 nm wavelengths. Res J Microbiol 2007;2:42-9.
18. Lindberg C, Horneck G. Action spectra for survival and spore photoproduct formation of Bacillus subtilis irradiated with short-wavelength (200-300 nm) UV at atmospheric pressure and in vacuo. J Photoch Photobio B 1991;11:69-80.
19. Lainer M, Mann E, Sönnichsen A. Information technology interventions to improve medication safety in primary care: a systematic review. Int J Qual Health Care 2013;25:590-8.
20. Mok W, Wang W, Cooper S et al. Attitudes towards vital signs monitoring in the detection of clinical deterioration: scale development and survey of ward nurses. Int J Qual Health Care 2015;27:207-13.
21. RahimzaiM, Amiri M, Burhani NH et al. Afghanistan's national strategy for improving quality in health care. Int J Qual Health Care 2013;25:270-6.
22. Anon EudraLex. The rules governing medicinal products in the European Union. EU guidelines to good manufacturing practice medicinal products for human and veterinary use, Vol. 4, European Commission - Enterprise and industry directorate-general. Consumer goods Pharmaceuticals, 25 November 2008.
23. Sobotka J. The efficiency of water treatment and disinfection by means of ultraviolet radiation. Water Sci Technol 1993;27:343-6.
24. Setlow P. Resistance of spores of Bacillus species to ultraviolet light. Environ Mol Mutagen 2001;38:97-104.
25. Setlow P. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 2006;101:514-25.
26. Setlow B, Setlow P. Role of DNA repair in Bacillus subtilis spore resistance. J Bacteriol 1996;178:3486-95.
27. Tennen R, Setlow B, Davis KL et al. Mechanisms of killing of spores of Bacillus subtilis by iodine, glutaraldehyde and nitrous acid. J Appl Microbiol 2000;89:330-8.
28. McDonnell G, Russell AD. Antiseptics and resistance: activity, action and resistance. Clin Microbiol Rev 1999;12:147-79.
29. Krämer I, Federici M, Kaiser V et al. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes. J Oncol Pharm Practice 2014; doi: 10.1177/1078155214565123.